Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 3, 2026

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
09:33

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

Published on: March 20, 2018

Oxidatively activated DNA-modifying agents for selective cytotoxicity.

Guorui Li1, Tiffany Bell, Edward J Merino

  • 1Department of Chemistry, University of Cincinnati, Cincinnati, OH 45221-0172, USA.

Chemmedchem
|March 5, 2011
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
Overview of DNA Repair02:25

Overview of DNA Repair

In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Straw input enhances soil organic carbon stabilization via physical protection and chemical stability.

Journal of environmental management·2026
Same author

Piezo1/2 in fibrosis: Cell-type-specific roles, organ-specific pathogenesis, and therapeutic implications.

Burns : journal of the International Society for Burn Injuries·2026
Same author

Comparative effectiveness of debridement strategies for chronic lower-extremity wounds: a systematic review and network meta-analysis.

Frontiers in medicine·2026
Same author

Bio-organic amendment enhances apple yield and nutritional quality in degraded sandy soils.

Frontiers in plant science·2026
Same author

[Surgical reconstruction selection and prognosis in congenital ossicular chain malformations].

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery·2026
Same author

CerS6 orchestrates mitochondrial-immune crosstalk via BNIP3-dependent mitophagy suppression and mtDNA-STING/NLRP3 activation in acute lung injury.

Cellular and molecular life sciences : CMLS·2026
Same journal

Fluorinated Aminopiperidones as Non-Glutarimide Thalidomide Analogs: Stereodivergent Synthesis and Validation.

ChemMedChem·2026
Same journal

Pharmacology, Medicinal Chemistry, and Therapeutic Potential of Imidazoline Receptor Ligands.

ChemMedChem·2026
Same journal

Drug Repurposing Against Cestode Fatty Acid Binding Proteins Through Integrated Virtual Screening and In Vitro Validation.

ChemMedChem·2026
Same journal

Investigating the Inhibitory Properties of Diazo and Pyrazole-Carboxamide-Linked Benzenesulfonamides Against Carbonic Anhydrase Isoforms I, II, IX, and XII.

ChemMedChem·2026
Same journal

Quinoxaline-Based Monoamine Oxidase Inhibitors: Design Strategies, Synthesis, Structure-Activity Relationships, and Therapeutic Potential in Neurological Disorders: A Review From 1996 to 2026.

ChemMedChem·2026
Same journal

Immunomodulatory Potential of Quinoline Q3, a Selective Inhibitor of the Canonical NF-κB Pathway in Macrophages.

ChemMedChem·2026
See all related articles

Novel DNA-modifying agents with an oxidizable leaving group and nitrogen mustard show enhanced selectivity in cancer treatment. These agents form strong electrophiles upon oxidation, leading to targeted DNA damage and reduced side effects compared to traditional chemotherapy.

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • Oncology

Background:

  • DNA-modifying agents are crucial in chemotherapy but lack selectivity and cause side effects.
  • Improvements in drug design are needed to enhance efficacy and patient outcomes.

Purpose of the Study:

  • To develop novel DNA-modifying agents with improved selectivity and reduced toxicity.
  • To investigate the mechanism of oxidative activation and its impact on DNA damage and cytotoxicity.

Main Methods:

  • Synthesis of novel DNA-modifying agents incorporating an oxidizable leaving group and a nitrogen mustard.
  • Assessment of oxidative activation using hydrolysis assays.
  • Evaluation of DNA lesion formation with 2'-deoxyguanosine.
  • Cytotoxicity assays in HeLa cells and 15 cancer cell lines, including 786-O kidney cancer cells.

More Related Videos

Single Molecule Analysis of Laser Localized Psoralen Adducts
11:46

Single Molecule Analysis of Laser Localized Psoralen Adducts

Published on: April 20, 2017

Quantitative Detection of DNA-Protein Crosslinks and Their Post-Translational Modifications
10:12

Quantitative Detection of DNA-Protein Crosslinks and Their Post-Translational Modifications

Published on: April 21, 2023

Related Experiment Videos

Last Updated: Jun 3, 2026

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
09:33

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

Published on: March 20, 2018

Single Molecule Analysis of Laser Localized Psoralen Adducts
11:46

Single Molecule Analysis of Laser Localized Psoralen Adducts

Published on: April 20, 2017

Quantitative Detection of DNA-Protein Crosslinks and Their Post-Translational Modifications
10:12

Quantitative Detection of DNA-Protein Crosslinks and Their Post-Translational Modifications

Published on: April 21, 2023

Main Results:

  • Oxidative activation increased agent reactivity by 1700-fold.
  • Low IC(50) values were dependent on the presence of both an oxidizable hydroquinone and a nitrogen mustard fragment.
  • The tested analogue demonstrated high selectivity, with IC(50) values < 10 μM in only 3 of 15 cell lines, unlike cisplatin.
  • Selective cytotoxicity was observed in 786-O kidney cancer cells (IC(50) = 5 μM).

Conclusions:

  • Oxidatively activated DNA-modifying agents represent a promising strategy for selective cancer chemotherapy.
  • This novel design offers potential for targeted cancer treatment with minimized off-target effects.
  • The observed selectivity suggests potential utility against specific cancer types, such as kidney cancer.